ALSV
ATP Life Science Ventures Portfolio holdings
AUM
$898M
This Quarter Return
-25.46%
1 Year Return
+84.86%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$898M
AUM Growth
+$898M
(-31%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stoke Therapeutics
STOK
$1.08B
| $667M | 74.2% | 17,161,713 | – | – |
|
2
Akero Therapeutics
AKRO
$3.74B
| $169M | 18.83% | 5,830,203 | – | – |
|
|
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $62.6M | 6.97% | 4,028,937 | – | – |
|